NOVEL STRAIN OF BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 AND USE THEREOF FOR THE TREATMENT AND/OR PREVENTION OF EXCESS WEIGHT AND OBESITY AND ASSOCIATED DISEASES
Bifidobacterium animalis subsp. lactisThe invention is applicable within the food and pharmaceutical industry. More specifically it relates to a novel strain of the species CECT 8145 the cell components metabolites and secreted molecules thereof which incorporated into food and/or pharmaceutical formulations can be used in the treatment and/or prevention of excess weight and obesity and related diseases such as metabolic syndrome hypertension glycemia inflammation type 2 diabetes cardiovascular diseases hypercholesterolemia hormonal alterations infertility etc.